CONSULTING AGREEMENTConsulting Agreement • February 28th, 2020 • Acorda Therapeutics Inc • Biological products, (no disgnostic substances) • New York
This Consulting Agreement (this "Agreement") is entered into on November 11, 2019, between Acorda Therapeutics, Inc., a Delaware corporation (the "Company"), and Jane Wasman ("Consultant"). This Agreement shall be effective (the "Effective Date") as of January 1, 2020, subject to the terms and conditions below:
